Abstract:Direct cell reprogramming, also called transdifferentiation, allows for the reprogramming of one somatic cell type directly into another, without the need to transition through an induced pluripotent state. Thus, it is an attractive approach to develop novel tissue engineering applications to treat diseases and injuries where there is a shortage of proliferating cells for tissue repair. In certain tissue damage, terminally differentiated somatic cells lose their ability to proliferate, as a result, damaged tissues cannot heal by themselves. Examples of these scenarios include myocardial infarctions, neurodegenerative diseases, and cartilage injuries. Transdifferentiation is capable of reprogramming cells that are abundant in the body into desired cell phenotypes that are able to restore tissue function in damaged areas. Therefore, direct cell reprogramming is a promising direction in the cell and tissue engineering and regenerative medicine fields. In recent years, several methods for transdifferentiation have been developed, ranging from the overexpression of transcription factors via viral vectors, to small molecules, to clustered regularly interspaced short palindromic repeats (CRISPR) and its associated protein (Cas9) for both genetic and epigenetic reprogramming. Overexpressing transcription factors by use of a lentivirus is currently the most prevalent technique, however it lacks high reprogramming efficiencies and can pose problems when transitioning to human subjects and clinical trials. CRISPR/Cas9, fused with proteins that modulate transcription, has been shown to improve efficiencies greatly. Transdifferentiation has successfully generated many cell phenotypes, including endothelial cells, skeletal myocytes, neuronal cells, and more. These cells have been shown to emulate mature adult cells such that they are able to mimic major functions, and some are capable of promoting regeneration of damaged tissue in vivo. While transdifferentiated cells have not yet seen clinical use, they have had promise in mice models, showing success in treating liver disease and several brain-related diseases, while also being utilized as a cell source for tissue engineered vascular grafts to treat damaged blood vessels. Recently, localized transdifferentiated cells have been generated in situ, allowing for treatments without invasive surgeries and more complete transdifferentiation. In this review, we summarized the recent development in various cell reprogramming techniques, their applications in converting various somatic cells, their uses in tissue regeneration, and the challenges of transitioning to a clinical setting, accompanied with potential solutions.

Direct Lineage Reprogramming to Neural Cells

Direct Reprogramming in Bone and Joint Degenerative Diseases: Applications, Obstacles and Directions

Direct Conversion of Somatic Cells into Induced Neurons

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Direct cell reprogramming: approaches, mechanisms and progress

Direct lineage reprogramming: strategies, mechanisms, and applications.

In Vivo Cellular Reprogramming: The Next Generation

Direct cell reprogramming for tissue engineering and regenerative medicine

Reprogramming lineage identity through cell-cell fusion

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

Toward Directed Reprogramming Through Exogenous Factors

Reprogramming Fibroblasts Toward Cardiomyocytes, Neural Stem Cells and Hepatocytes by Cell Activation and Signaling-Directed Lineage Conversion

Direct reprogramming: converting one type of terminally differentiated cell directly into another

Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons.

Reprogramming cell fates by small molecules

Next-generation direct reprogramming

Instant Neurons: Directed Somatic Cell Reprogramming Models of Central Nervous System Disorders

Direct Cell Reprogramming and Phenotypic Conversion: An Analysis of Experimental Attempts to Transform Astrocytes into Neurons in Adult Animals

Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells